Pay in 4 interest-free payments of $5.87 Learn more
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8
The most commonly observed side effects in controlled clinical studies, 5% or greater and at least 1.5 times placebo, in adults include paraesthesia, dizziness, dysgeusia, insomnia, constipation, and dry mouth
Combinations of Treatment Methods As GLP-1 RA and amylin analog-induced weight loss arise from both distinct and overlapping mechanisms, the combination of GLP-1 RA and amylin RA has been shown to produce a synergistic effect [118]
Adverse GI effects were only marginally less prevalent with tirzepatide
This product includes a high content of vitamin B6 , which contributes to normal energy metabolism and the reduction of tiredness and fatigue
Piramal Pharma sterile injectable and fill-finish capacity, including for high-volume chronic injectables
Before reconstitution Lyophilized powder storage: Room temperature: Fine for months Refrigerator (2-8C): Extends shelf life to 12-24 months Freezer (-20C): Maximum shelf life (24-36 months) Keep in original packaging, protect from light Don't: Leave in hot car Expose to direct sunlight Open vial until ready to reconstitute Get moisture inside vial After reconstitution Critical: Refrigerate immediately: Store at 2-8C (36-46F) Main fridge section, not door (too much temperature fluctuation) Use within 28-30 days maximum Discard if cloudy or discolored Daily use: Remove from fridge briefly to draw dose Return to fridge immediately Don't leave out for hours Each removal should be 5 years continuous use) When to stop and consult physician: Severe or persistent side effects Allergic reaction (rash, difficulty breathing) Unexpected symptoms Contraindications Avoid BPC-157 if: Pregnant or breastfeeding (no safety data) Active cancer (theoretical tumor growth concern) Severe allergic reaction to previous dose Use caution if: Taking blood thinners (BPC-157 may affect coagulation) Scheduled for surgery (stop 1-2 weeks before) Significant health conditions (consult physician) See our peptide safety and risks guide
